E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures.
Anyanwu, Ebere, Campbell, Andrew W, Jones, Joseph et al. · TheScientificWorldJournal · 2003 · DOI
Quick Summary
This review examines how toxic molds found in homes and buildings can damage the immune system, specifically affecting natural killer cells—white blood cells that help fight infections. When people are exposed to these molds over time, their natural killer cells may stop working normally, which could contribute to symptoms like fatigue, memory problems, sleep trouble, depression, headaches, and fevers that resemble ME/CFS.
Why It Matters
For ME/CFS patients and researchers, this work suggests a potential biological mechanism—immune dysregulation via mycotoxin exposure—that could explain overlapping symptoms of fatigue, cognitive dysfunction, and sleep disturbance. If mold exposure-induced NKC abnormalities are verified experimentally, it could guide environmental screening and immune-targeted interventions for a subset of ME/CFS patients.
Observed Findings
- Chronic toxigenic mold exposure is associated with abnormal natural killer cell activity
- Mycotoxins can interfere with circadian rhythm processes and sleep regulation
- Mold exposure presents with neurological symptoms including headache, memory loss, depression, mood swings, sleep disturbance, anxiety, chronic fatigue, and seizures
- Myocotoxin-induced NKC dysfunction may occur at low physiological concentrations
Inferred Conclusions
- Chronic mold exposure can lead to abnormal NKC activity with wide-ranging neurological consequences
- Mycotoxins disrupt immune function and circadian rhythm regulation, contributing to symptom clustering
- Abnormal NKC activity may be a mechanistic link between environmental mold exposure and systemic symptoms resembling chronic fatigue syndrome
Remaining Questions
- What are the specific mycotoxins most damaging to NKC function, and at what exposure thresholds do they cause measurable immune dysfunction?
- How prevalent is clinically significant mold exposure as a cofactor or trigger in ME/CFS populations?
- Do patients with confirmed ME/CFS show different NKC abnormalities than those with mold exposure alone, and can NKC activity be restored by removing mold exposure?
What This Study Does Not Prove
This literature review does not establish that mold exposure causes ME/CFS or that abnormal NKC activity is a primary driver of ME/CFS symptoms in typical patients. The study does not present original patient data, comparative controls, or direct measurement of NKC dysfunction in exposed versus unexposed individuals, so it cannot prove causation or quantify risk. The overlap between mold-exposure symptoms and ME/CFS symptoms does not prove they share the same etiology.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigueTemperature Dysregulation
Biomarker:CytokinesBlood Biomarker
Method Flag:Weak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1100/tsw.2003.98
- PMID
- 14625399
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →